RecallDepth
Class II Terminated

Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories

This recall has been terminated (originally issued July 17, 2019).

Company
American Health Packaging
Recall Initiated
May 9, 2019
Posted
July 17, 2019
Recall Number
D-1467-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
375,921 bottles
Firm Location
Columbus, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

Distribution

Nationwide USA

Lot / Code Info

Count, Lot, Expiry: [30-count bottle] Lots M711214, M711215, M711216, M711217, exp 8/31/2019; Lots M802198, M802199, exp 1/31/2020; Lots M805203, M805204, M805207, exp 3/31/2019; Lots M812455, exp 6/30/2020; Lot M815766, exp 9/30/2020; Lots M818633, M818634, exp 10/31/2020; Lots M819858, M819859, exp 11/30/2020 [1000-count bottle] Lot M711218, exp 8/31/2019; Lot M802197, exp 1/31/2020; Lots M805209, M805946, exp 3/31/2020; Lot M812456, exp 6/30/2020; Lots M815767, M818273, exp 9/30/2020; Lot M819857, exp 11/30/2020

More recalls by American Health Packaging

View all recalls by this company →

Other recent Class II Drug recalls